Key contribution of CPEB4-mediated translational control to cancer progression (Q39433508)

11 September 2017

title

Key contribution of CPEB4-mediated translational control to cancer progression (English)

1 reference

11 September 2017

9

1 reference

11 September 2017

Pilar Navarro

12

0 references

R Méndez

object named as

Raúl Méndez

11

0 references

Francisco X Real

object named as

Francisco X Real

10

0 references

author name string

Elena Ortiz-Zapater

1

1 reference

11 September 2017

David Pineda

2

1 reference

11 September 2017

Neus Martínez-Bosch

3

1 reference

11 September 2017

Gonzalo Fernández-Miranda

4

1 reference

11 September 2017

Mar Iglesias

5

1 reference

11 September 2017

Francesc Alameda

6

1 reference

11 September 2017

Mireia Moreno

7

1 reference

11 September 2017

Carolina Eliscovich

8

1 reference

11 September 2017

language of work or name

English

0 references

publication date

4 December 2011

1 reference

11 September 2017

1 reference

11 September 2017

volume

18

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

83-90

1 reference

11 September 2017

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Regulation of translation initiation in eukaryotes: mechanisms and biological targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Translational control in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

A combinatorial code for CPE-mediated translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

A deadenylation negative feedback mechanism governs meiotic metaphase arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Spindle-localized CPE-mediated translation controls meiotic chromosome segregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Translational control by CPEB: a means to the end

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Translational control from head to tail

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Meiosis requires a translational positive loop where CPEB1 ensues its replacement by CPEB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

CPEB3 and CPEB4 in neurons: analysis of RNA-binding specificity and translational control of AMPA receptor GluR2 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Control of cellular senescence by CPEB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

CPEB: a life in translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

MYC as a regulator of ribosome biogenesis and protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

The gene encoding the splicing factor SF2/ASF is a proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

The connection between splicing and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

The splicing-factor oncoprotein SF2/ASF activates mTORC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Alternative splicing in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Reprogramming of 3' untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Regulation of cell signalling by uPAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

The urokinase plasminogen activator system: a target for anti-cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

The plasminogen activator system and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Plasminogen activator in mouse and rat oocytes: induction during meiotic maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Transient translational silencing by reversible mRNA deadenylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Mechanisms governing the control of mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

A five-gene signature and clinical outcome in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Increased microRNA activity in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Expression of CPEB, GAPDH and U6snRNA in cervical and ovarian tissue during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM.2540

Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/22138752

12 December 2020

Meiotic maturation of mouse oocytes triggers the translation and polyadenylation of dormant tissue-type plasminogen activator mRNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/22138752

12 December 2020

Behavior of transforming growth factors in serum-free media: an improved assay for transforming growth factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22138752

12 December 2020

Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo

1 reference

https://pubmed.ncbi.nlm.nih.gov/22138752

12 December 2020

The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/22138752

12 December 2020

Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22138752

12 December 2020

Isolation of tissue-type plasminogen activator, cathepsin H, and non-specific cross-reacting antigen from SK-PC-1 pancreas cancer cells using subtractive hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/22138752

12 December 2020

Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22138752

12 December 2020

Identifiers

DOI

10.1038/NM.2540

1 reference

11 September 2017

1 reference